EC50 (M ± S.E.M.) | Emax (% ± S.E.M) | |
---|---|---|
(a) CONTROL | ||
Non-treated | 2.6×10−6 ± 1.2×10−6 | 274.1 ± 47.1 |
Progesterone-pretreated | 1.7×10−6 ± 7.8×10−7 ns | 94.0 ± 14.4 ** |
(b) BRL 44408 | ||
Non-treated | 1.8×10−6 ± 6.4×10−6 | 364.3 ± 70.8 |
Progesterone-pretreated | 1.2×10−5 ± 4.8 ×10−6 ns | 57.4 ± 12.9 *** |
(c) ARC 239 | ||
Non-treated | 1.2×10−6 ± 1.1×10−6 | 147.1 ± 79.4 |
Progesterone-pretreated | 5.3×10−6 ± 1.5×10−6 ns | 83.7 ± 22.1* |
(d) SPIROXATRINE | ||
Non-treated | 1.6×10−6 ± 5.4×10−6 | 382.4 ± 93.5 |
Progesterone-pretreated | 5.9×10−6 ± 1.4×10−6 ns | 41.0 ± 15.2 *** |
(e) BRL 44408 + SPIROXATRINE | ||
Non-treated | 2.9×10−6 ± 8.4×10−7 | 444.6 ± 51.3 |
Progesterone-pretreated | 2.8×10−6 ± 2.7 ×10−5 ns | 102.9 ± 32.62 *** |